Cardiorespiratory fitness trumps BMI in predicting risk of death and heart disease

As rates of obesity, as defined by body mass index (BMI), continue to climb in the United States, so have efforts to lose weight, including a new era of weight-loss drugs.

Padcev, Keytruda’s new survival data; Seraxis raises $10M for diabetes cell therapy

Padcev, Keytruda’s confirmatory win: Astellas and Seagen said Friday that Padcev and Merck’s Keytruda helped certain bladder cancer patients live longer than chemotherapy in a

September 23, 2023

Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression and launches new research center | Psychedelic Invest

UK sites to participate in part of pivotal phase 3 program following Medicines and Healthcare Regulatory Agency approval of study Research will take place in

November 16, 2023

Massachusetts Psychiatrists Push Back on Psychedelic Reform as Ballot Vote Looms: An Interview with Nassir Ghaemi – Psychedelic Alpha

Ghaemi told me that he is concerned that a regulated psychedelics program in Massachusetts could cause harms. The more widespread use of psychedelics could, in

October 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.